Trial Profile
Phase II study of antineoplastons A10 and AS2-1 in children with low grade astrocytoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Astrocytoma
- Focus Therapeutic Use
- 22 Sep 2016 Status changed from recruiting to completed.
- 18 Aug 2005 New trial record.